Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 2–2 | Cite as

Gastrointestinal CMV infection/reactivation with ipilimumab

News item
  • 55 Downloads

Reference

  1. Medicines and Healthcare products Regulatory Agency (UK). Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation. Drug Safety Update 12: 4-5, No. 6, Jan 2019. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/770006/PDF-Jan-2019-publication.pdf Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations